Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Q32 Bio Inc (QTTB)

Q32 Bio Inc (QTTB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Q32 Bio Inc 830 WINTER STREET WALTHAM MA 02451 USA

www.q32bio.com Employees: 7 P: 781-999-0232

Description:

Q32 Bio Inc. is a clinical stage biotechnology company developing biologic therapeutics to restore immune homeostasis. Q32 Bio Inc., formerly known as Homology Medicines Inc., is based in WALTHAM, Mass.

Key Statistics

Overview:

Market Capitalization, $K 565,573
Enterprise Value, $K 526,303
Shares Outstanding, K 11,942
Annual Sales, $ 1,160 K
Annual Net Income, $ -112,960 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -16,980 K
EBIT, $ -75,860 K
EBITDA, $ -78,230 K
60-Month Beta -0.32
% of Insider Shareholders 16.10%
% of Institutional Shareholders 31.32%
Float, K 10,019
% Float 83.90%
Short Volume Ratio 0.69

Growth:

1-Year Return 140.57%
3-Year Return -57.71%
5-Year Return -79.86%
5-Year Revenue Growth -68.48%
5-Year Earnings Growth 9.01%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.42 on 08/08/24
Next Earnings Date 11/12/24
Earnings Per Share ttm -29.14
EPS Growth vs. Prev Qtr 89.20%
EPS Growth vs. Prev Year 87.06%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-18 on 03/26/24

QTTB Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -129.44%
Return-on-Assets % -62.88%
Profit Margin % -9,737.93%
Debt/Equity 0.37
Price/Sales 467.27
Price/Cash Flow N/A
Price/Book 15.47
Book Value/Share 2.81
Interest Coverage -1.15
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar